Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1

Cancer stem cells in neuroblastoma therapy resistance

Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement

Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies

Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs

Exosomal lncRNAs: the newest promising liquid biopsy

In search of effective therapies to overcome resistance to Temozolomide in brain tumours

Kinase inhibitors: look beyond the label on the bottle

Liquid biopsies in myeloid malignancies

Liquid biopsy in metastatic breast cancer

Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics

MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution

Network rewiring, adaptive resistance and combating strategies in breast cancer

Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence

RET in breast cancer: pathogenic implications and mechanisms of drug resistance

Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked DNA-adducts

The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia

The role of exosomal long non-coding RNAs in cancer drug resistance

Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathways

Components of the human-specific, p53-mediated “kill switch” tumor suppression mechanism are usurped by human tumors, creating the possibility of therapeutic exploitation

Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer

Actions for 0 selected articles

Cancer Drug Resistance
ISSN 2578-532X (Online)
Follow Us


All published articles will preserved here permanently:



All published articles will preserved here permanently: